Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
Changing market sentiment about Box Inc. consistent losses as it goes after rapid growth, with one anayst calling it "a house of horrors," a long IPO process and investor demands, have an unnerving and distracting effect on the founders. Langley and Hardy describe the experience of startup founders as competition and market perceptions change.
Linked Articles
Rich, but Not Silicon Valley Rich for Founders of Box
Wall Street Journal 04/24/2015
Box, Provider of Cloud-Computing Services, Faces Make-or-Break MomentNew York Times 04/19/2015
Linked Articles
Three Fears for Facebook as IPO Approaches
Wall Street Journal 05/17/2012
Here Are 10 Reasons Not to Buy Facebook Before You Buy It AnywayWall Street Journal 05/17/2012
John Taylor and the Ifo Institue's Sinn say the recapitalization of Greece's banks and the lower interest rates negotiated after the March 2012 bailout make exiting the euro and achieving economic growth doable. The Papdemos government's need for time till 2015 to complete the program of changes, and the elections in April 2012 in which opposition parties outpolled Pasok and New Democrachy lays the political groundwork for the exit.
Linked Articles
Greece at new risk of being pushed off euro - The Washington Post
Washington Post 05/08/2012
A Better Grecian BailoutWall Street Journal 02/22/2012
Linked Articles
Wall Street Journal 04/03/2012
The Missed Red Flags on GrouponNew York Times 10/18/2011
How Foxconn is adapting to the changes by increasing wages in Shenzen, increasing automation, and shifting plants to lower wage regions in the interior of China, and to Brazil.
Linked Articles
Foxconn to Raise Salaries for Workers by Up to 25%
New York Times 02/18/2012
Foxconn: How to Beat the High Cost of Happy WorkersBusinessWeek 05/05/2011
Bankia was the new name for seven troubled cajas savings banks that were merged. The failure of the government's handling of the bad real estate debt, the collapse of the IPO price for bankia's IPO, and the insovency followed by takeover of Bankia by the government, is what led to the $125 recapitalization request by Spain to the EU. The cajas in Galicia give an insight into the operation of these savings banks, in many cases run by leaders who became influential in the political system and expanded healvily int real estate during the bubble years. Management remained in place for decades with authoritarian leaders and there were no financial controls.
Linked Articles
Clash of Cultures Upends Spain's Cajas
New York Times 08/20/2012
Spain to Recapitalize Bankia in Latest BailoutWall Street Journal 05/24/2012
Linked Articles
IPO Analysts Warn of Longer-Term Facebook Risks
Wall Street Journal 05/14/2012
Facebook Insiders Boost Plans to Cash Out in IPOWall Street Journal 05/17/2012
Linked Articles
Wall Street Journal 02/22/2012
INTERVIEW: Ifo's Sinn: In Greece's Interest To Leave Euro ZoneWall Street Journal 02/17/2012
A move away from coal used for electricity supplies towards nuclear energy. The increase planned is from 11 gigawatts of nuclear energy in 2012 to 40 gigawatts by 2015 and 60-70 gigawatts by 2020. Five nuclear energy projects will be planned at a cost of $27 billion with financing help from a Shanghai IPO offering in 2012.
Linked Articles
China Nuclear Firm Plans Up to $27 Billion IPO
Wall Street Journal 06/06/2012
China Marches On With Nuclear Energy, in Spite of FukushimaNew York Times 10/10/2011
Rathmann's focus on EPO when Amgen was near bankruptcy in the mid-1980's saved the company. By 1989 Amgen had secured FDA approval for Epogen, a hormone based drug to stimulate the production of red blood cells. This is a rare success in a biotech industry with many failed startup ventures or ventures strugglig with only 6-12 months of cash remaining.
Linked Articles
Cash Dries Up for Biotech Drug Firms
Wall Street Journal 03/16/2009
Amgen's First CEOWall Street Journal 04/23/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1